First Trust NYSE Arca Biotechnology Index Fund
222 hedge funds and large institutions have $1.77B invested in First Trust NYSE Arca Biotechnology Index Fund in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 56 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 227 → 222 (-5)
5% less capital invested
Capital invested by funds: $1.86B → $1.77B (-$93.3M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
222
Holding in Top 10
6
Calls
$2.37M
Puts
$1.25M
Top Buyers
| 1 | +$63.3M | |
| 2 | +$14.3M | |
| 3 | +$6.83M | |
| 4 |
Goldman Sachs
New York
|
+$5.6M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.83M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$21.2M | |
| 3 | -$20.6M | |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
-$19.2M |
| 5 |
GA
Gateway Advisory
Westfield,
New Jersey
|
-$7.49M |